Elisabeth Leiderman
Direktor/Vorstandsmitglied bei BLUEBIRD BIO, INC.
Vermögen: 20 320 $ am 30.04.2024
Aktive Positionen von Elisabeth Leiderman
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| BLUEBIRD BIO, INC. | Direktor/Vorstandsmitglied | 15.10.2021 | - |
| Independent Dir/Board Member | 15.10.2021 | - | |
| AUTOLUS THERAPEUTICS PLC | Direktor/Vorstandsmitglied | 20.12.2023 | - |
Karriereverlauf von Elisabeth Leiderman
Ehemalige bekannte Positionen von Elisabeth Leiderman
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Atsena Therapeutics, Inc.
 Atsena Therapeutics, Inc. BiotechnologyHealth Technology Atsena Therapeutics, Inc. engages in biotechnology business. The company is headquartered in Durham, NC. | Finanzdirektor/CFO | 07.11.2022 | 01.11.2023 |
| DECIBEL THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 09.09.2021 | 07.10.2022 |
| Finanzdirektor/CFO | 01.09.2020 | 07.10.2022 | |
Complexa, Inc.
 Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | Corporate Officer/Principal | 01.11.2016 | 01.08.2020 |
| Nomura Securities, Inc. | Direktor/Vorstandsmitglied | 01.01.2013 | 01.07.2016 |
| FORTRESS BIOTECH, INC. | Corporate Officer/Principal | 01.01.2007 | 01.01.2016 |
Ausbildung von Elisabeth Leiderman
| University of Pennsylvania | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| Sackler School of Medicine | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 9 |
| Israel | 2 |
| Vereinigtes Königreich | 2 |
Operativ
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
| Director of Finance/CFO | 2 |
Sektoral
| Health Technology | 7 |
| Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| FORTRESS BIOTECH, INC. | Health Technology |
| DECIBEL THERAPEUTICS, INC. | Health Technology |
| BLUEBIRD BIO, INC. | Health Technology |
| AUTOLUS THERAPEUTICS PLC | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | Health Technology |
| Nomura Securities, Inc. | |
Atsena Therapeutics, Inc.
Atsena Therapeutics, Inc. BiotechnologyHealth Technology Atsena Therapeutics, Inc. engages in biotechnology business. The company is headquartered in Durham, NC. | Health Technology |
- Börse
- Insiders
- Elisabeth Leiderman
- Erfahrung
